lisdexamfetamine dimesilate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
VYVANSE lisdexamfetamine dimesilate 40 mg capsules bottle AUST R: 284020Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
22 Jan 2024
to
30 Apr 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
Emergency Supply of VYVANSE lisdexamfetamine dimesilate 40mg capsule bottle AUST R: 284020 is available from the sponsor. Please contact Takeda Pharmaceuticals Australia Pty Ltd on 1800 012 612 or medinfoapac@takeda.com for details on supply.
A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortages-vyvanse-lisdexamfetamine-dimesilate-capsules
|
VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle AUST R: 284021Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
18 Dec 2023
to
30 Apr 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
Emergency Supply of VYVANSE lisdexamfetamine dimesilate 60mg capsule bottle AUST R: 284021 is available from the sponsor. Please contact Takeda Pharmaceuticals Australia Pty Ltd on 1800 012 612 or medinfoapac@takeda.com for details on supply.
An unregistered product has also been approved for supply under Section 19A.The approval holder, Medsurge can be contacted for details on supply on: 1300 788 261 or sales@medsurge.com.au
A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortages-vyvanse-lisdexamfetamine-dimesilate-capsules
|
VYVANSE lisdexamfetamine dimesilate 30mg capsule bottle AUST R: 199227Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
07 Aug 2023
to
26 Mar 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle AUST R: 199226Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
03 Nov 2023
to
07 Mar 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|